# A Study of Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan

> **NCT04828772** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 9282 (actual)

## Conditions studied

- COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04828772
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-17
- **Primary completion:** 2021-01-31
- **Final completion:** 2022-02-07
- **Target enrollment:** 9282 (ACTUAL)
- **Last updated:** 2022-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04828772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04828772, "A Study of Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04828772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*